Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Feng Fu

Showing results (641-650 of 682) with videos related to

Pageof 69
Sort By:
Physiological Measurement|December 28, 2020
Positive end-expiratory pressure titration with electrical impedance tomography and pressure-volume curve: a randomized trial in moderate to severe ARDSHui-Ju Hsu, Hou-Tai Chang, Zhanqi Zhao, et al.
Basic & Clinical Pharmacology & Toxicology|February 8, 2013
Total synthetic protoapigenone WYC02 inhibits cervical cancer cell proliferation and tumour growth through PIK3 signalling pathwayYun-Ju Chen, Nari Kay, Jinn-Moon Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 6, 2005
S-adenosyl-L-homocysteine hydrolase inactivation curtails ovalbumin-induced immune responsesYun-Feng Fu, Jun-Xia Wang, Yang Zhao, et al.
Fundamental & Clinical Pharmacology|February 4, 2024
Angiotensin 1-7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart-The signaling mechanismIvan A Derkachev, Sergey V Popov, Leonid N Maslov, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 6, 2005
Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivoYi-Na Zhu, Wei-Min Zhao, Yi-Fu Yang, et al.
Current Cardiology Reviews|April 15, 2022
Reperfusion Cardiac Injury: Receptors and the Signaling MechanismsLeonid N Maslov, Sergey V Popov, Alexandr V Mukhomedzyanov, et al.
Viral Immunology|May 20, 2014
siRNA against KIR3DL1 as a potential gene therapeutic agent in controlling HIV-1 infectionGeng-Feng Fu, Ji-Cheng Pan, Nan Lin, et al.
Clinical and Experimental Medicine|September 26, 2024
Personalized neoantigen cancer vaccines: current progression, challenges and a bright futureDa-Wei Wu, Shuo-Peng Jia, Shu-Jun Xing, et al.
Journal of Biomedical Research|July 28, 2023
A historical literature review of coronary microvascular obstruction and intra-myocardial hemorrhage as functional/structural phenomenaLeonid N Maslov, Natalia V Naryzhnaya, Sergey V Popov, et al.
Neural Regeneration Research|May 10, 2022
Silencing miRNA-324-3p protects against cerebral ischemic injury via regulation of the GATA2/A1R axisAn-Qi Zhang, Lu Wang, Yi-Xiu Wang, et al.
Pageof 69

Showing results (641-650 of 682) with videos related to

Sort By:
Pageof 69
Physiological Measurement|December 28, 2020
Positive end-expiratory pressure titration with electrical impedance tomography and pressure-volume curve: a randomized trial in moderate to severe ARDSHui-Ju Hsu, Hou-Tai Chang, Zhanqi Zhao, et al.
Basic & Clinical Pharmacology & Toxicology|February 8, 2013
Total synthetic protoapigenone WYC02 inhibits cervical cancer cell proliferation and tumour growth through PIK3 signalling pathwayYun-Ju Chen, Nari Kay, Jinn-Moon Yang, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 6, 2005
S-adenosyl-L-homocysteine hydrolase inactivation curtails ovalbumin-induced immune responsesYun-Feng Fu, Jun-Xia Wang, Yang Zhao, et al.
Fundamental & Clinical Pharmacology|February 4, 2024
Angiotensin 1-7 increases cardiac tolerance to ischemia/reperfusion and mitigates adverse remodeling of the heart-The signaling mechanismIvan A Derkachev, Sergey V Popov, Leonid N Maslov, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 6, 2005
Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivoYi-Na Zhu, Wei-Min Zhao, Yi-Fu Yang, et al.
Current Cardiology Reviews|April 15, 2022
Reperfusion Cardiac Injury: Receptors and the Signaling MechanismsLeonid N Maslov, Sergey V Popov, Alexandr V Mukhomedzyanov, et al.
Viral Immunology|May 20, 2014
siRNA against KIR3DL1 as a potential gene therapeutic agent in controlling HIV-1 infectionGeng-Feng Fu, Ji-Cheng Pan, Nan Lin, et al.
Clinical and Experimental Medicine|September 26, 2024
Personalized neoantigen cancer vaccines: current progression, challenges and a bright futureDa-Wei Wu, Shuo-Peng Jia, Shu-Jun Xing, et al.
Journal of Biomedical Research|July 28, 2023
A historical literature review of coronary microvascular obstruction and intra-myocardial hemorrhage as functional/structural phenomenaLeonid N Maslov, Natalia V Naryzhnaya, Sergey V Popov, et al.
Neural Regeneration Research|May 10, 2022
Silencing miRNA-324-3p protects against cerebral ischemic injury via regulation of the GATA2/A1R axisAn-Qi Zhang, Lu Wang, Yi-Xiu Wang, et al.
Pageof 69